Related Experiment Video
Updated: Apr 5, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Erythropoietin and Neonatal Neuroprotection
Sandra E Juul1, Gillian C Pet1
1Division of Neonatology, Department of Pediatrics, University of Washington, 1959 Northeast Pacific Street, Box 356320, Seattle, WA 98195-6320, USA.
Insights
Certain newborns face high risks of neurodevelopmental impairment and may benefit from neuroprotection. Erythropoietin (Epo) shows potential as a neuroprotective agent for neonatal brain injury, with ongoing clinical trials in infants.
Area of Science:
- Neonatal neurology
- Neuroprotection
- Developmental neuroscience
Background:
- Specific neonate groups are susceptible to long-term neurodevelopmental impairment.
- Understanding neonatal brain injury mechanisms is crucial for effective interventions.
- Cellular injury and death pathways in the neonatal brain require detailed investigation.
Purpose of the Study:
- To identify high-risk neonatal groups for neurodevelopmental impairment.
- To explore mechanisms underlying neonatal brain injury and cellular damage.
- To discuss the neuroprotective potential of erythropoietin (Epo) in neonates.
Main Methods:
- Review of high-risk neonatal populations.
- Analysis of neonatal brain injury mechanisms.
- Examination of cellular injury and death processes.
- Discussion of erythropoietin's (Epo) role in neuroprotection.
Main Results:
- Identified specific neonatal groups at high risk for neurodevelopmental deficits.
- Elucidated key mechanisms of brain injury and cellular demise in neonates.
- Erythropoietin (Epo) presents a promising therapeutic avenue for neonatal neuroprotection.
Conclusions:
- Erythropoietin (Epo) holds significant potential for protecting the neonatal brain.
- Further clinical investigation is warranted to confirm Epo's efficacy in preterm and term infants.
- Targeted neuroprotective strategies are essential for high-risk neonates.
Abstract:
Certain groups of neonates are at high risk of developing long-term neurodevelopmental impairment and might be considered candidates for neuroprotective interventions. This article explores some of these high-risk groups, relevant mechanisms of brain injury, and specific mechanisms of cellular injury and death. The potential of erythropoietin (Epo) to act as a neuroprotective agent for neonatal brain injury is discussed. Clinical trials of Epo neuroprotection in preterm and term infants are updated.
Related Concept Videos
Erythropoiesis
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Neurogenesis and Regeneration of Nervous Tissue
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...

